Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4217965
Max Phase: Preclinical
Molecular Formula: C20H26O2
Molecular Weight: 298.43
Molecule Type: Small molecule
Associated Items:
ID: ALA4217965
Max Phase: Preclinical
Molecular Formula: C20H26O2
Molecular Weight: 298.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(CCCCCCCc2ccccc2O)cc1
Standard InChI: InChI=1S/C20H26O2/c1-22-19-15-13-17(14-16-19)9-5-3-2-4-6-10-18-11-7-8-12-20(18)21/h7-8,11-16,21H,2-6,9-10H2,1H3
Standard InChI Key: OGLWBPXGSOGEAQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 298.43 | Molecular Weight (Monoisotopic): 298.1933 | AlogP: 5.14 | #Rotatable Bonds: 9 |
Polar Surface Area: 29.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.30 | CX Basic pKa: | CX LogP: 6.27 | CX LogD: 6.27 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.65 | Np Likeness Score: 0.19 |
1. McLane RD, Le Cozannet-Laidin L, Boyle MS, Lanzillotta L, Taylor ZL, Anthony SR, Tranter M, Onorato AJ.. (2018) Synthesis and PGE2 inhibitory activity of novel diarylheptanoids., 28 (3): [PMID:29290543] [10.1016/j.bmcl.2017.12.046] |
Source(1):